MedPath

Clinical Research Project to Evaluate Effects and Fruitfulness of Unani Medicine in Treatment of Melasma (Hindi: Jhayeen)

Phase 2
Conditions
Health Condition 1: L811- Chloasma
Registration Number
CTRI/2023/09/057430
Lead Sponsor
Jamia Hamdard (Deemed to be university)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of all genders, belonging to 18 to 60 years of age and willing to participate in the trial voluntarily.

Clinically diagnosed patients of epidermal melasma using Wood’s lamp (340-400 nm).

Patients willing to sign the informed consent form.

Exclusion Criteria

Pregnant and lactating women.

Female patient using oral contraceptives.

Patients having field work jobs.

Patients with drug or alcohol addiction.

Patients with uncontrolled diabetes mellitus, renal disorders, severe liver, and heart diseases.

Patients have used bleaching creams or topical steroid creams such as Azeliac acid, tretinoin and hydroquinone in the past 4 weeks before entering in the study.

Patients who have undergone any laser therapies and chemical peeling or consuming photosensitizing substances in past 4 weeks.

Patients having thyroid disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in MASI Scale <br/ ><br>Reduction in Melasma QoL Index <br/ ><br>Reduction in PGATimepoint: 1st,14th,28th,42nd,56th
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath